User's Manual
Table Of Contents
- Table of contents
- List of figures
- CHAPTER 1 Description
- CHAPTER 2 Indications and contraindications
- CHAPTER 3 Personal Pump Communicator (PPC)
- CHAPTER 4 Pump implantation
- Preprogramming and pre-testing the Pump
- CHAPTER 5 Pump refill procedure
- CHAPTER 6 Explanting the Pump System
- CHAPTER 7 Warnings and precautions
- CHAPTER 8 Adverse reactions
- CHAPTER 9 System alarms and messages
- Pump alarms
- Alarm feedback
- Pump low battery
- Depleted pump battery
- System error
- Pump self test fail
- PPC low battery
- PPC alarms
- Low reservoir
- Empty reservoir
- Telemetry communication error
- Initialize alarm
- PPC not initialized
- Battery replacement
- Initialize to factory defaults
- Pump stopped
- Pump suspended
- Auto off
- Hourly maximum exceeded
- Pump alarm table
- Pump alarms
- CHAPTER 10 Troubleshooting Pump System under-delivery
- CHAPTER 11 Technical specifications
- APPENDIX A Label information symbol dictionary
- APPENDIX B Implant worksheet
- APPENDIX C Refill form
- APPENDIX D Precautions and general procedures
- APPENDIX E Pump rinse procedure
- APPENDIX F Side Port Catheter flush procedure
- Supplies and solutions
- Preparing for the procedure
- Flushing the Side Port Catheter
- Program minimal basal rate
- Remove insulin and fill with rinse buffer
- Equilibrate and pull rinse buffer through system
- Flush side port catheter
- Remove rinse buffer and fill with insulin
- Equilibrate and pull insulin through system
- Remove guide needles and record refill amount
- Program new basal rate
- Remove rinse buffer from catheter
- APPENDIX G Stroke volume measurement
Indications and contraindications
10
Possible adverse effects
The model 2007D is essentially identical to the model 2007C Pump except for
the change in gas needed to maintain negative pressure in the reservoir.
Evaluation of components used in the Medtronic MiniMed 2007C system has
spanned a period of approximately 4 years and involved approximately 380
patients from both the U.S. and Europe. Although clinically relevant over-
delivery of insulin did not occur during the 4 year evaluation period, there is a
potential for such an occurrence.
The following are specific adverse effects which should be understood by the
physician and explained to the patient. These do not include all adverse effects
which can occur with surgery in general or with the use of this device, but are
important considerations, particularly in the treatment of diabetic patients. The
general surgical risks, as well as operative site cosmetic risks, should be
explained to the patient prior to surgery.
• Abdominal Pain • Foreign Body Reaction
• Inflammation at Refill Site • Skin Erosion
• Infection • Pocket Lymph Edema
• Necrosis • Hyperglycemia
• Hypoglycemia • Ketoacidosis